Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

A cost-effectiveness analysis of inhaled corticosteroid delivery for children with asthma in the emergency department.

Andrews AL, Teufel RJ 2nd, Basco WT Jr, Simpson KN.

J Pediatr. 2012 Nov;161(5):903-7. doi: 10.1016/j.jpeds.2012.05.015. Epub 2012 Jun 18.

PMID:
22717219
2.

A cost-effectiveness analysis of dexamethasone versus prednisone in pediatric acute asthma exacerbations.

Andrews AL, Wong KA, Heine D, Scott Russell W.

Acad Emerg Med. 2012 Aug;19(8):943-8. doi: 10.1111/j.1553-2712.2012.01418.x. Epub 2012 Jul 31.

3.

Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma.

Adams RJ, Fuhlbrigge A, Finkelstein JA, Lozano P, Livingston JM, Weiss KB, Weiss ST.

Pediatrics. 2001 Apr;107(4):706-11.

PMID:
11335748
4.

Low rates of controller medication initiation and outpatient follow-up after emergency department visits for asthma.

Andrews AL, Teufel RJ 2nd, Basco WT Jr.

J Pediatr. 2012 Feb;160(2):325-30. doi: 10.1016/j.jpeds.2011.07.037. Epub 2011 Aug 31.

PMID:
21885062
5.

Impact of omalizumab on emergency-department visits, hospitalizations, and corticosteroid use among patients with uncontrolled asthma.

Lafeuille MH, Dean J, Zhang J, Duh MS, Gorsh B, Lefebvre P.

Ann Allergy Asthma Immunol. 2012 Jul;109(1):59-64. doi: 10.1016/j.anai.2012.04.015. Epub 2012 May 12.

PMID:
22727159
6.

Inadequate follow-up controller medications among patients with asthma who visit the emergency department.

Cydulka RK, Tamayo-Sarver JH, Wolf C, Herrick E, Gress S.

Ann Emerg Med. 2005 Oct;46(4):316-22.

PMID:
16187464
7.

Inhaled corticosteroid use and outcomes in pregnancy.

Schatz M, Leibman C.

Ann Allergy Asthma Immunol. 2005 Sep;95(3):234-8.

PMID:
16200813
8.

Anti-inflammatory medication adherence and cost and utilization of asthma care in a commercially insured population.

Mattke S, Martorell F, Hong SY, Sharma P, Cuellar A, Lurie N.

J Asthma. 2010 Apr;47(3):323-9. doi: 10.3109/02770900903497196.

PMID:
20394518
9.
10.

Community asthma initiative: evaluation of a quality improvement program for comprehensive asthma care.

Woods ER, Bhaumik U, Sommer SJ, Ziniel SI, Kessler AJ, Chan E, Wilkinson RB, Sesma MN, Burack AB, Klements EM, Queenin LM, Dickerson DU, Nethersole S.

Pediatrics. 2012 Mar;129(3):465-72. doi: 10.1542/peds.2010-3472. Epub 2012 Feb 20.

11.

Inhaled corticosteroids vs leukotriene receptor antagonists: health care costs across varying asthma severities.

O'Connor RD, Parasuraman B, Roberts C, Leibman C.

Ann Allergy Asthma Immunol. 2006 Aug;97(2):236-43.

PMID:
16937758
12.

Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma.

Johansson G, Andreasson EB, Larsson PE, Vogelmeier CF.

Pharmacoeconomics. 2006;24(7):695-708. Erratum in: Pharmacoeconomics. 2008;26(10):894.

PMID:
16802845
13.

Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma.

Sin DD, Man SF.

Arch Intern Med. 2002 Jul 22;162(14):1591-5.

PMID:
12123402
14.

Anticoagulation monitoring by an anticoagulation service is more cost-effective than routine physician care.

Aziz F, Corder M, Wolffe J, Comerota AJ.

J Vasc Surg. 2011 Nov;54(5):1404-7. doi: 10.1016/j.jvs.2011.05.021. Epub 2011 Jul 13.

15.

[Impact of inhaled corticosteroid prescription at discharge from the emergency room on exacerbations of asthma in Japanese hospital].

Chohnabayashi N, Sugiyama K, Kato M, Kimura T, Mochiduki H, Yasuba H, Yoshihara S, Fukuda T, Morikawa A, Adachi M.

Arerugi. 2010 Feb;59(2):123-36. Japanese.

PMID:
20212354
16.

Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors.

Ducharme FM, Noya FJ, Allen-Ramey FC, Maiese EM, Gingras J, Blais L.

Curr Med Res Opin. 2012 Jan;28(1):111-9. doi: 10.1185/03007995.2011.640668. Epub 2011 Dec 16. Review.

PMID:
22077107
17.

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.

Main C, Shepherd J, Anderson R, Rogers G, Thompson-Coon J, Liu Z, Hartwell D, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

Health Technol Assess. 2008 May;12(20):1-174, iii-iv. Review.

18.

Quality improvement methods improve inhaled corticosteroid prescribing in the emergency department.

Andrews AL, Russell WS, Titus MO, Braden J, Word C, Cochran C, Adams S, Roberts JR.

J Asthma. 2014 Sep;51(7):737-42. doi: 10.3109/02770903.2014.911885. Epub 2014 May 14.

PMID:
24697737
19.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
20.

Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs.

Stempel DA, O'Donnell JC, Meyer JW.

J Allergy Clin Immunol. 2002 Mar;109(3):433-9.

PMID:
11897987
Items per page

Supplemental Content

Write to the Help Desk